Vera Therapeutics (VERA) PT Raised to $61 at Guggenheim
Tweet Send to a Friend
(Updated - February 27, 2025 7:29 AM EST)
Guggenheim analyst Vamil Divan raised the price target on Vera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Vamil Divan raised the price target on Vera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


